Altogether, our study highlighted a novel role of ACY1 in the radiotherapy of cetuximab-resistant CRC, suggesting a possible target for cetuximab-resistant CRC treatment in the clinic. The gene discussed is ACY1; the disease is colorectal carcinoma.